{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:11Z","timestamp":1761863051043,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.medcli.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:11:03Z","timestamp":1701537063000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diferencias cl\u00ednicas entre la amiloidosis cardiaca por transtirretina y la cardiopat\u00eda hipertensiva"],"prefix":"10.1016","volume":"162","author":[{"given":"Ignacio","family":"Gallo-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Gonz\u00e1lez-Manzanares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Pericet-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Jes\u00fas","family":"Carmona-Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Perea-Armijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Castillo-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Anguita-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.10.006_bib0165","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2023.10.006_bib0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2023.10.006_bib0175","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1157\/13126044","article-title":"Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE Study","volume":"61","author":"Anguita S\u00e1nchez","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2023.10.006_bib0185","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2023.10.006_bib0190","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2023.10.006_bib0195","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG Features and Arrhythmic Profile in Trnasthyretin Versus Light Chain Cardiac Amyloidosis","volume":"13","author":"Cappeli","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.medcli.2023.10.006_bib0200","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2008.12.013","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part III: Intraventricular conduction diturbances: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee","volume":"53","author":"Surawicz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.14364","article-title":"Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan","author":"Naito","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.medcli.2023.10.006_bib0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s13023-022-02584-3","article-title":"Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country","volume":"17","author":"Szor","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2023.10.006_bib0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagn\u00f3stico y tratamiento de la amiloidosis cardiaca por trantiretina: Progreso y esperanza","volume":"70","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0220","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jchf.2021.05.005","article-title":"Sex- Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS","volume":"9","author":"Caponetti","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.medcli.2023.10.006_bib0225","first-page":"16e0254104","article-title":"Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction","author":"Goland","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2023.10.006_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-019-0132-x","article-title":"Blood pressure and heart failure","volume":"26","author":"Oh","year":"2020","journal-title":"Clin Hypertens"},{"key":"10.1016\/j.medcli.2023.10.006_bib0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","article-title":"Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Hartnett","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0240","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/S0002-9149(03)00227-3","article-title":"Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/M17-0996","article-title":"Trends in Racial\/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014","volume":"168","author":"Brown","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2023.10.006_bib0250","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1152\/japplphysiol.00374.2015","article-title":"Myocardial Hypertrophy and Its Role in Heart Failure with Preserved Ejection Fraction","volume":"119","author":"Heinzel","year":"2015","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.medcli.2023.10.006_bib0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11739-011-0647-y","article-title":"Cardiac amyloidosis: The heart of the matter","volume":"8","author":"Perfetto","year":"2013","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.medcli.2023.10.006_bib0260","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.08720811","article-title":"Transthyretin amyloidosis and the kidney","volume":"7","author":"Lobato","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/769103","article-title":"Renal Function in Patients with Hypertension Associated Congestive Cardiac Failure Seen in a Tertiary Hospital","author":"Osuji","year":"2012","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0270","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2011.04.133","article-title":"Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs","volume":"410","author":"Bourgault","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.medcli.2023.10.006_bib0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13506129.2020.1769059","article-title":"Cardiac sympathetic denervation in wild-type transthyretin amyloidosis","volume":"27","author":"Gimelli","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.medcli.2023.10.006_bib0280","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0285","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","article-title":"Familial Amyloid Polyneuropathy: Receptor for Advanced Glycation End Products-Dependent Triggering of Neuronal Inflammatory and Apoptotic Pathways","volume":"21","author":"Sousa","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.medcli.2023.10.006_bib0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.medcli.2021.09.022","article-title":"Alteraciones electrocardiogr\u00e1ficas y necesidad de marcapasos en amiloidosis cardiaca: an\u00e1lisis de 58 casos","volume":"159","author":"Pericet Rodriguez","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2023.10.006_bib0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: The great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.medcli.2023.10.006_bib0300","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/01.CIR.103.12.e69","article-title":"Pseudoinfarctions","volume":"103","author":"Cheng","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2023.10.006_bib0305","doi-asserted-by":"crossref","first-page":"e003795","DOI":"10.1161\/JAHA.116.003795","article-title":"Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass","volume":"6","author":"Maanja","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2023.10.006_bib0310","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2023.10.006_bib0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00392-019-01490-2","article-title":"When and how do patients with cardiac amyloidosis die?","volume":"109","author":"Escher","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.medcli.2023.10.006_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179546817751609","article-title":"Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction","volume":"12","author":"Nanayakkara","year":"2018","journal-title":"Clin Med Insights Cardiol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323006073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323006073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:57:33Z","timestamp":1758419853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323006073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0025775323006073"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.10.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diferencias cl\u00ednicas entre la amiloidosis cardiaca por transtirretina y la cardiopat\u00eda hipertensiva","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}